Скачать или смотреть Who Will Control India's Future of Medicines ?

The fight for India’s online pharmacy market is heating up between Tata 1mg and Reliance Netmeds. Tata 1mg is the current leader with a 31% share and nearly ₹2400 crore revenue in FY25, backed by Tata Digital’s deep pockets. But despite its scale, it’s still burning money.

On the other side, Reliance Netmeds holds 15–18% share and reported a ₹58 crore profit last year. With Reliance Retail and Jio’s massive supply chain, Netmeds is betting on reach and pricing power.

Tata focuses on “tech & trust,” while Reliance pushes “reach & price.” With 70 million homes expected to order medicines online by 2025, this battle isn’t just about market share it’s about who will shape the future of India’s healthcare.